Cynthia Smith

Cynthia Smith is recorded as Board Member at Agios Pharmaceuticals, Inc. (AGIO), Board Member at Protara Therapeutics, Inc. (TARA) and Board Member at Spero Therapeutics, Inc. (SPRO). The newest filing on record that lists Cynthia Smith as Board Member at Agios Pharmaceuticals, Inc. (AGIO) is dated April 24, 2026. The newest filing on record that lists Cynthia Smith as Board Member at Protara Therapeutics, Inc. (TARA) is dated April 28, 2026. Cynthia Smith was last confirmed as Board Member at Akebia Therapeutics, Inc. (AKBA) in a filing dated April 25, 2024. Agios Pharmaceuticals, Inc. reported in an 8-K filed June 18, 2026 that Cynthia Smith was appointed Class I director, effective June 18, 2026. Agios Pharmaceuticals, Inc. reported in an 8-K filed June 14, 2023 that Cynthia Smith was appointed Class I director, effective June 13, 2023. Agios Pharmaceuticals, Inc. reported in an 8-K filed May 25, 2023 that Cynthia Smith was appointed chair of the Compensation & People Committee, effective May 24, 2023. Equibles holds 4 filed executive changes naming Cynthia Smith; each is listed under recent activity with its source filing. Agios Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Protara Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Agios Pharmaceuticals, Inc. includes Brian Goff (CEO and Board Member), Jacqualyn Fouse (CEO and Board Member), David P. Schenkein (Chairman) and 7 others.